These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17615090

  • 1. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
    Wu T, Rifai N, Willett WC, Rimm EB.
    Am J Epidemiol; 2007 Sep 01; 166(5):544-51. PubMed ID: 17615090
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory markers and the risk of coronary heart disease in men and women.
    Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB.
    N Engl J Med; 2004 Dec 16; 351(25):2599-610. PubMed ID: 15602020
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, Arveiler D, Fruchart JC, Ducimetiere P, PRIME Study Group.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1255-61. PubMed ID: 12775578
    [Abstract] [Full Text] [Related]

  • 4. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
    Shai I, Pischon T, Hu FB, Ascherio A, Rifai N, Rimm EB.
    Obesity (Silver Spring); 2006 Nov 01; 14(11):2099-106. PubMed ID: 17135628
    [Abstract] [Full Text] [Related]

  • 5. Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies".
    Meerwaldt R, Links T, Zeebregts C, Smit A.
    Am J Epidemiol; 2008 Mar 15; 167(6):756-7. PubMed ID: 18296707
    [No Abstract] [Full Text] [Related]

  • 6. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P, PRIME Study Group.
    Circulation; 2005 May 10; 111(18):2299-305. PubMed ID: 15867179
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
    Lowe GD, Rumley A, McMahon AD, Ford I, O'Reilly DS, Packard CJ, West of Scotland Coronary Prevention Study Group.
    Arterioscler Thromb Vasc Biol; 2004 Aug 10; 24(8):1529-34. PubMed ID: 15205218
    [Abstract] [Full Text] [Related]

  • 8. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):973-9. PubMed ID: 16949489
    [Abstract] [Full Text] [Related]

  • 9. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.
    Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB.
    Arch Intern Med; 2008 Apr 14; 168(7):713-20. PubMed ID: 18413553
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
    Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V.
    N Engl J Med; 2004 Apr 01; 350(14):1387-97. PubMed ID: 15070788
    [Abstract] [Full Text] [Related]

  • 11. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W.
    Circulation; 2005 Aug 02; 112(5):651-7. PubMed ID: 16043640
    [Abstract] [Full Text] [Related]

  • 12. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT.
    Arterioscler Thromb Vasc Biol; 2004 Aug 02; 24(8):1503-8. PubMed ID: 15178568
    [Abstract] [Full Text] [Related]

  • 13. Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies.
    Wu T, Willett WC, Rifai N, Rimm EB.
    Am J Epidemiol; 2007 Sep 01; 166(5):552-60. PubMed ID: 17615091
    [Abstract] [Full Text] [Related]

  • 14. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S, LIPID Study Investigators.
    Eur Heart J; 2008 Apr 01; 29(7):923-31. PubMed ID: 18296678
    [Abstract] [Full Text] [Related]

  • 15. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
    van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC.
    Arch Intern Med; 2003 Jun 09; 163(11):1323-8. PubMed ID: 12796068
    [Abstract] [Full Text] [Related]

  • 16. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM.
    Circulation; 2004 Jul 20; 110(3):292-300. PubMed ID: 15238458
    [Abstract] [Full Text] [Related]

  • 17. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study.
    Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H.
    Nutr Metab Cardiovasc Dis; 2006 Jan 20; 16(1):13-21. PubMed ID: 16399487
    [Abstract] [Full Text] [Related]

  • 18. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM.
    Circulation; 2008 Feb 12; 117(6):823-31. PubMed ID: 18227386
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M, Scharnagl H, Koenig W, Brenner H.
    Eur J Cardiovasc Prev Rehabil; 2003 Oct 12; 10(5):362-70. PubMed ID: 14663298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.